On September 1, 2015, Illumina, Inc. (NASDAQ: ILMN) announced it had completed the acquisition of GenoLogics Life Science Software Inc., a developer of laboratory information management systems for life sciences organizations.
Fasken’s Keith Spencer (technology) and Iain Mant (M&A) advised GenoLogics on the transaction.
